Philips paves the way for faster lung cancer diagnosis and treatment with advanced 3D imaging and navigation platform - Seite 2

“Lung cancer is one of the most aggressive forms of cancer, and we need innovative technology to fight back,” said Dr. Gustavo Cumbo-Nacheli, Director of Bronchoscopy and Interventional Pulmonology at Spectrum Health in Grand Rapids, Michigan, U.S. “Without a Cone Beam CT scan to confirm placement of the biopsy needle, repeat procedures are often necessary. And by combining Cone Beam CT with other technologies, including robotics, we will be able to go beyond biopsy and treat the patient.”

On Wednesday, September 23 at 13:00 ET (19:00 CET). Dr. Atul Gupta, Interventional Radiologist and Chief Medical Officer, Philips Image Guided Therapy, will host an exclusive virtual roundtable together with a panel of renowned pulmonologists and interventional radiologists, “The Future Now: Implementing Cone Beam CT-guided endobronchial ablation therapy”. To register, click here.

“Image-guided minimally invasive procedures continue to expand into new treatment areas, enabled by sophisticated, procedure-oriented solutions like Azurion Lung Edition,” said Dr. Gupta. “With lung cancer increasingly being detected at an earlier stage, new minimally invasive treatment strategies like ablation have the potential to significantly improve outcomes for patients.”

Intuitive, integrated and efficient, the Azurion platform optimizes clinical and operational lab performance and expands the role of image-guided interventions in the treatment of patients. The platform has achieved rapid global adoption and has been used in well over two million procedures [3] worldwide.

Philips Azurion Lung Edition is available now in the U.S.

[1] American Cancer Society: Cancer Facts & Figures 2013.
[2] Kanarek et al., Survival after community diagnosis of early-stage non-small cell lung cancer. The American journal of medicine. 127, no. 5 (2014): 443-449.
[3] Based on Philips’ internal case and procedure data.

For further information, please contact:

Mark Groves
Philips Global Press Office
Tel: [phone]
Email: [e-mail]

Twitter: mark_groves

Fabienne van der Feer
Philips Image Guided Therapy
Tel: [phone]
Email: [e-mail]

Twitter: FC_Feer

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

 

Attachments

• Philips-Azurion-lung-ablation
• Philips-Azurion-Lung-Edition